Additive manufacturing has developed into a powerful class of technologies for space flight, while 3D bioprinting is also attracting growing interest of the international space agencies. Bioprinting allows for the manufacturing of 3D cell and tissue constructs that can be utilized in space to investigate the specific effects of stressors, such as microgravity and cosmic radiation. In addition, bioprinting techniques possess the opportunity to fabricate clinically applicable human tissues that might contribute to the autonomous medical treatment options for injured astronauts on future long‐term and far‐distant space missions.
The specific limitations connected to space flight are challenging for the establishment of the bioprinting process chain. However, microgravity is believed to also provide significant advantages for several bioprinting methods compared to conventional conditions applying on Earth. This includes the opportunity to use low viscous bioinks in extrusion‐based bioprinting that will prevent the sedimentation of cells or other particulate matter both in bioinks and resins. Consequently, the scientific community is excited about the possibility to investigate bioprinting processes and the development of bioprinted cell constructs under real space conditions at the ISS once the ESA has commissioned the construction of respective hardware. For effective utilization of such devices, equipment with cameras and sensors is required to allow the scientists on ground to follow and control the experimental procedures.









